Evidence map›Paper›PMID 41962867›Full record

ArticleThe Journal of biological chemistry2026

Structural basis for the mechanism and stability of the EEPD1 5' endonuclease.

Robert A Hromas, Aruna S Jaiswal, Anurag Misra, Yaxia Yuan, Daohong Zhou, John I Beckman, Shailee Arya, Adhishree Chidambaram, Alexander B Taylor, Wendell Griffith and 3 more

Abstract read
In one paragraph

Article in The Journal of biological chemistry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Robert A HromasDepartment of Medicine and the Mays Cancer Center, The University of Texas at San Antonio, San Antonio, Texas, USA. Electronic address: hromas@uthscsa.edu.
Aruna S JaiswalDepartment of Medicine and the Mays Cancer Center, The University of Texas at San Antonio, San Antonio, Texas, USA.
Anurag MisraDepartment of Biochemistry and Structural Biology and the Greehey Children's Cancer Research Institute, The University of Texas at San Antonio, San Antonio, Texas, USA.
Yaxia YuanDepartment of Biochemistry and Structural Biology and the Center for Innovative Drug Discovery, The University of Texas at San Antonio, San Antonio, Texas, USA.
Daohong ZhouDepartment of Biochemistry and Structural Biology and the Center for Innovative Drug Discovery, The University of Texas at San Antonio, San Antonio, Texas, USA.
John I BeckmanDepartment of Biochemistry and Structural Biology and the Greehey Children's Cancer Research Institute, The University of Texas at San Antonio, San Antonio, Texas, USA.
Shailee AryaDepartment of Biochemistry and Structural Biology and the Greehey Children's Cancer Research Institute, The University of Texas at San Antonio, San Antonio, Texas, USA.
Adhishree ChidambaramDepartment of Biochemistry and Structural Biology and the Greehey Children's Cancer Research Institute, The University of Texas at San Antonio, San Antonio, Texas, USA.
Alexander B TaylorDepartment of Biochemistry and Structural Biology and the Greehey Children's Cancer Research Institute, The University of Texas at San Antonio, San Antonio, Texas, USA.
Wendell GriffithDepartment of Chemistry, The University of Texas at San Antonio, San Antonio, Texas, USA.
Arunima JaiswalDepartment of Medicine and the Mays Cancer Center, The University of Texas at San Antonio, San Antonio, Texas, USA.
Elizabeth A WilliamsonDepartment of Medicine and the Mays Cancer Center, The University of Texas at San Antonio, San Antonio, Texas, USA.
Yogesh K GuptaDepartment of Biochemistry and Structural Biology and the Greehey Children's Cancer Research Institute, The University of Texas at San Antonio, San Antonio, Texas, USA. Electronic address: guptay@uthscsa.edu.

Funding

Mechanism-based Targeting of the RNA Processing Machinery of SARS-CoV-2R01AI161363 · NIAID · UNIVERSITY OF TEXAS HLTH SCIENCE CENTER · PI GUPTA, YOGESH K · 2021 to 2025
$3.2M
NIAID NIH HHS R01 AI161363
6 · The paper itself

Abstract

The 5' endonuclease EEPD1 initiates repair of replication forks stalled at oxidative DNA damage. EEPD1 has abasic endonuclease activity that can replace APE1 and initiate base excision repair when the cell is overwhelmed with oxidative DNA damage. In this study, we investigated the structural basis of this activity using X-ray crystallography in conjunction with in vitro endonuclease assays. We resolved the X-ray crystallographic structure of the EEPD1 nuclease domain to 3.2 Å resolution, revealing electrostatic and π-stacking interactions at the homodimeric interface. We further validated the finding that EEPD1 exists as dimers in solution using SEC-MALS analysis, mass photometry, and native gel electrophoresis. Mutations at hydrophobic tryptophans at positions W517, W522, and W524 disrupted the dimerization interface, resulting in a predominantly monomeric EEPD1. While the disruption of dimerization moderately decreased EEPD1's nuclease activity, it significantly decreased its intracellular half-life. We found, as predicted, that catalytic site residues Q269, H404, and D448 are crucial for EEPD1's abasic endonuclease activity, consistent with their structurally predicted role. The EEPD1 catalytic site exhibits geometric conservation of shape and charge in key regions with the APE1's catalytic site, even though these nucleases are otherwise evolutionarily divergent. In summary, these data define the structural basis for the assembly, stability, and endonuclease activity of EEPD1.

Indexed as

EndonucleasesCatalytic DomainCrystallography, X-RayEnzyme StabilityExcision RepairHumansModels, MolecularEndonucleasesAPE1base excision repairdimerizationDNA damageEEPD1endonuclease

Identifiers

PMID41962867
PMCPMC13153614

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.